Session Type
Meeting
Search Results for Hospital at Home
Abstract Number: 0027
SHM Converge 2025
Background: Hospital at Home (HaH) provides inpatient level of care to patients within their homes and replaces the brick and mortar inpatient experience. Our institution’s HaH program has had incredible success and has enrolled over 2000 patients to date and continues to expand. The growth of our program has allowed us to accept more complex [...]
Abstract Number: 0239
SHM Converge 2025
Background: The Center for Medicare and Medicaid Services (CMS) enables Medicare-certified hospitals to provide inpatient-level care at home through their Acute Hospital Care at Home (AHCAH) initiative. A CMS report on 9/30/24 revealed demographic differences between AHCAH patients and traditional inpatients from the same hospitals. AHCAH patients were more likely to be white, live in [...]
Abstract Number: 0242
SHM Converge 2025
Background: Hospital-at-home programs deliver hospital-level care in the comfort of patients’ homes, offering an innovative alternative to traditional hospitalization. These programs have gained traction since the COVID-19 pandemic and Medicare’s expanded reimbursements for virtual visits. Studies have demonstrated that they effectively manage heart failure with outcomes comparable to traditional hospital care. In 2020, Kaiser Permanente [...]
Abstract Number: 0251
SHM Converge 2025
Background: Hospital at Home (HaH) delivers hospital-level care to eligible patients in their homes, offering an alternative to traditional inpatient hospitalization. Longitudinal research has demonstrated that HaH can enhance patient outcomes, increase satisfaction, and decrease rates of hospital readmissions. Patients are first identified for HaH program enrollment through referrals by inpatient providers or our internal [...]
Abstract Number: 0290
SHM Converge 2025
Background: Michigan Medicine’s Hospital Care at Home (HCAH) Program was designed to provide eligible patients living in Southeast Michigan hospital level care from their own homes. Since the advent of the CMS Hospital at Home Waiver in Nov 2020, 93% of HCAH programs have been in urban locations, with prominent programs in cities such as [...]
Abstract Number: 0357
SHM Converge 2025
Background: Hospital at Home (HaH) is an expanding clinical model that delivers inpatient-level care to patients in their homes, substituting a traditional hospital stay. It is becoming a standard of care at many institutions, yet there are still few formally established processes for integrating medical trainees despite clear benefits for both the program’s growth and [...]
Abstract Number: 0359
SHM Converge 2025
Background: Hospital-at-Home (HaH) is a novel care model providing inpatient care for patients in their home through a combination of home visits and virtual care. Advanced Care at Home (ACH), UNC Health’s HaH program, launched in 2021, has helped over 2,000 admissions to date. The majority of HaH care is provided under the terms of [...]
Abstract Number: 0376
SHM Converge 2025
Background: Hospital-at-Home (HaH) is a novel care model providing inpatient care for patients in their home through a combination of home visits and virtual care. Advanced Care at Home (ACH), UNC Health’s HaH program, launched in 2021, has facilitated over 2,000 admissions to date. The majority of HaH care is provided under the terms of [...]
Abstract Number: 0392
SHM Converge 2025
Background: Efficiently identifying clinically appropriate patients is integral to the operation and growth of a hospital at home program. Given the nuances of a home-based care delivery model, this task typically relies on a specifically trained small group of experienced providers, significantly limiting the number of patients able to be screened. The Hospital at Home [...]
Abstract Number: 0398
SHM Converge 2025
Background: Patients undergoing induction chemotherapy for acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) often experience prolonged hospital stays due to the length of induction therapy, follow-up bone marrow biopsies, and count recovery. While the average length of stay (LOS) for these patients may exceed 30 days, most diagnosis-related groups (DRGs) assign a LOS [...]